The importance of offering early genetic testing in everyone with amyotrophic lateral sclerosis

Several genetically-targeted therapies are being developed for ALS. Research is increasingly supportive of a greater incidence of clinically actionable variants in sporadic ALS than previously reported. Salmon et al. outline the need to improve access, and offer genetic testing to all people diagnos...

Descripción completa

Detalles Bibliográficos
Autores principales: Salmon, Kristiana, Kiernan, Matthew C., Kim, Seung H., Andersen, Peter M., Chio, Adriano, van den Berg, Leonard H., Van Damme, Philip, Al-Chalabi, Ammar, Lillo, Patricia, Andrews, Jinsy A., Genge, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Special Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129091/
https://www.ncbi.nlm.nih.gov/pubmed/35020823
http://dx.doi.org/10.1093/brain/awab472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9129091/
https://www.ncbi.nlm.nih.gov/pubmed/35020823
http://dx.doi.org/10.1093/brain/awab472

Ejemplares similares